NYU
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
At AACR, the company highlighted new prospective and retrospective data that it believes helps set its platform apart from other available ctDNA technologies.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
NYU Langone Health Gets FDA Clearance for Solid Tumor Gene Sequencing Test
The test uses next-generation sequencing to detect cancer-linked mutations in 607 genes to help guide patient treatment.
Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial
The company is planning to commercialize its cancer early detection technology initially in lung cancer and is working with NYU researchers to explore future expansions.